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Abstract: Nutrition has been established as a relevant factor in the development of cardiovascular
disease (CVD). We aimed to investigate the relationship between the dietary inflammatory index
(DII) and cardiometabolic risk parameters in a cohort of 90 overweight and sedentary adults from
Bogotá, Colombia. A 24-h dietary record was used to calculate the DII. Body composition variables,
flow-mediated dilation (FMD), pulse wave velocity (PWV), lipid profile, glucose, glycosylated
hemoglobin (Hb1Ac), and blood pressure were measured and a cardiometabolic risk score (MetScore)
was calculated. A lower DII score (anti-inflammatory diet) was significantly associated with higher
high-density lipoprotein-cholesterol (HDL-C) and FMD, and lower Hb1Ac and MetScore (p < 0.05).
A lower DII score was inversely correlated with plasma triglyceride levels (r = −0.354, p < 0.05),
glucose (r = −0.422, p < 0.05), MetScore (r = −0.228, p < 0.05), and PWV (r = −0.437, p < 0.05),
and positively with FMD (r = 0.261, p < 0.05). In contrast, a higher DII score (pro-inflammatory diet)
showed a positive relationship with MetScore (r = 0.410, p < 0.05) and a negative relationship with
FMD (r = −0.233, p < 0.05). An increased inflammatory potential of diet was inversely associated with
an improved cardiometabolic profile, suggesting the importance of promoting anti-inflammatory
diets as an effective strategy for preventing CVD.
Keywords: dietary inflammatory index; cardio-metabolic; diet; overweight
1. Introduction
Low-grade chronic inflammation has been established as a relevant factor in the development
of cardiovascular disease (CVD) [1]. It is characterized by increased circulating levels of cytokines
with inflammatory activity and acute-phase proteins (C-Reactive Protein; CRP), interleukins (IL-1,
IL-6), and tumor necrosis factor alpha (TNF-α), among others—as well as by increased infiltration
of macrophages in peripheral tissue [2]. Evidence has shown that lifestyles, especially dietary
factors, may modulate this process [3–5]. Thus, nutrition plays an important role in the development
of atherogenesis and cardiovascular events [3,6].
In this context, it has been indicated that dietary patterns characterized by a high intake
of saturated and trans unsaturated fatty acids may lead to alterations in endothelial function [7,8].
The “Western” diet, rich in red meats, fats, and carbohydrates, has been positively associated with
markers of low-grade subclinical inflammation, while dietary patterns based on fruits, vegetables,
olive oil, and whole grains have shown an inverse relationship [3,4,9]. In addition, the Mediterranean
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food pattern, which is a well-known anti-inflammatory diet, exerts a protective effect against free
radicals and oxidants [10].
A dietary pattern comprising high amounts of fish, yogurt, vegetables, pasta, greens, fruit,
and wine also has the potential to reduce circulating levels of inflammatory markers [3]. Diet-based
anti-inflammatory components, including omega-3 fatty acids, vitamins B1 (thiamine), B2 (riboflavin)
and B3 (niacin), folic acid, vitamin A, vitamin C, vitamin E, beta-carotene, magnesium, and zinc,
have been identified [11].
On this basis, researchers from the University of South Carolina in the United States designed
the dietary inflammatory index (DII), a tool for assessing the inflammatory diet profile based
on 45 nutritional parameters. Due to their anti-inflammatory or pro-inflammatory properties,
these nutritional factors were associated with markers of inflammation including CRP, interleukins
IL-1β, IL-4, IL-6 and IL-10, and TNF-α [12]. The DII has been reported to be associated with
several inflammatory processes, such as obesity, insulin resistance, cardiovascular risk, and several
types of cancer [13–16]. However, to the best of our knowledge, the DII has not been used
to evaluate inflammatory properties of diet in Latin Americans, characterized by increasing
total fat, animal products, and sugar intakes [14], particularly in the Colombian population.
Since Latin Americans have different dietary habits and morbidity and mortality indicators, it is
of particular interest.
Recently, there has been a surge of interest in developing strategies with a more cost-effective
approach and fewer side effects, which is useful in clinical practice aimed at preventing CVD.
Among the non-pharmacological strategies, physical activity and diet are considered the cornerstones
of cardiovascular prevention. Taking all this evidence into account, we aimed to investigate the
relationship between the DII and cardiometabolic risk parameters in a cohort of overweight and
sedentary adults from Bogotá, Colombia.
Our hypothesis is that higher DII scores (pro-inflammatory diet defined by positive values) are
associated with an increased cardiometabolic risk profile, independently of other risk factors such as
age and gender.
2. Materials and Methods
2.1. Study Design
A secondary analysis of the clinical trial High Intensity Interval- vs. Resistance or Combined-
Training to Improve Cardiometabolic Health in Overweight Adults: Cardiometabolic HIIT-RT Study
ClinicalTrials.gov Identifier: NTC02715063 was carried out between 2016 and 2017 [17]. The study was
performed in accordance with the Declaration of Helsinki (2000) and was approved by the Human
Ethics Committee of Manuela Beltrán University (Code N◦ 06-1006-2014; Resolution 008430/2003 by
the Colombian Ministry of Health). Written informed consent was obtained from each participant.
2.2. Participants
The sample comprised 90 women and men, with excess body weight (BMI ≥ 26 and ≤ 35 kg/m2),
who were sedentary (individuals who do not engage in five or more days of moderate physical activity
or walking for at least 30 min per session, or who do not engage in three or more days per week of
vigorous physical activity for 20 min, as assessed by the International Physical Activity Questionnaire
(IPAQ) [18], and who met at least one of the criteria of metabolic syndrome as established by the
International Diabetes Federation [18]. The study cohort was selected through a call for volunteers.
Exclusion criteria included medical diagnosis of hypertension, hypo/hyperthyroidism, history of
alcohol and drug abuse, use of lipid-lowering medications, or drugs capable of modifying the lipid
profile four weeks before the study, following hypocaloric diets to lose weight and suffering from
inflammatory or infectious processes.
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2.3. Procedures
Participants completed questionnaires regarding medical history including personal and family
history of CVD, smoking status (number of cigarettes/day), alcohol consumption (grams of
alcohol/day), physical activity (min/week), and medication use.
Anthropometric measurements, including height, weight, waist circumference (WC), and hip
circumference (HC), were evaluated according to standardized protocols for the Colombian population
established by the World Health Organization (WHO) [19]. Height was measured to the nearest 0.1 cm
using a portable stadiometer (SECA 206®, range 0–220 cm, Seca GmbH &. Co, Hamburg, Germany).
To measure weight, we used an electronic scale (Seca mBCA 515® HANS E. RÜTH S.A, Allers Co,
Hamburg, Germany). Body mass index (BMI) was calculated as weight over height squared (kg/m2).
An anthropometric a metal tape (Lufkin W606PM®, Allers Co, Parsippany, NJ, USA), with an accuracy
of ± 1 mm was used to measure hip circumferences according to anatomical references established by
the WHO [20]. Body composition parameters, including fat and lean mass in grams and percentage
(trunk, gynecoid, android, android/gynecoid (A/G) fat quotient) and total tissue, were measured by
dual-energy X-ray absorptiometry (DXA, Hologic Mod Explorer®, 4500 C/W QDR, INC 35 Crosby
Drive, Bedford, USA), and the regions of interest (ROIs) were selected. These measurements were
performed after 10–12 h of fasting.
Blood pressure was taken with an automatic monitor (Omrom® HEM 705 CP, Health-care Co,
Kyoto, Japan) following the recommendations of the European Heart Society (on the right arm,
with participants in a supine position and after 10 min of rest). Mean arterial pressure (MAP) was
calculated using the following formula: (2 (systolic blood pressure (SBP) + diastolic blood pressure
(DBP))/3).
Capillary blood samples (40 µL) were collected for determining serum biochemical parameters,
including fasting glucose, triglycerides (TG), high-density lipoprotein-cholesterol (HDL-C), and total
cholesterol (TC) using portable Cardiocheck® equipment (Mexglobal SA, Parsippany, NJ, USA).
Low-density lipoprotein-cholesterol (LDL-c) was calculated using Friedewald’s Formula when
triglyceride values were ≤400 mg/Dl [21]. Glycated hemoglobin (Hb1Ac) was measured using
A1cNow + (Bayer®, Mexglobal SA, Terrytown, NY, USA). Blood samples were drawn between 07:00
and 09:00, after 10–12 h of fasting (11.2 h on average). A cardiometabolic risk score (MetScore) was
calculated as the sum of the typified Z-scores per age and gender from the following components: WC,
TG, HDL-C, glucose, and MAP [18]. MetScore = ((♂40 or ♀50 − HDL-C)/SD × (−1)) + ((triglycerides
− 150)/SD) + ((glucose − 100)/SD) + ((WC − ♂90 or ♀80)/SD) + ((MAP − 100)/SD). Cut-off points to
calculate the MetScore were determined according to the International Diabetes Federation criteria [18].
A MetScore standard deviation score ≥1 was considered to represent a high risk of CVD.
Brachial artery flow-mediated dilation (FMD) was used as a measure of endothelium-dependent
vasodilation. The peripheral vessel ultrasound evaluation was performed with a high-resolution
ultrasound system (Mindray M-9®, Invermedica LTDA, Shenzhen, China), with a 7.5 MHz linear
array probe to locate and interrogate flow velocity profiles in the right brachial artery. Ultrasound
images were obtained after 20 min of rest in a supine position in a dark, climate-controlled, quiet room
(22–24 ◦C), with the participant’s arm immobilized and slightly supinated and elevated. An additional
10 min of rest was allowed before the opposite arm was imaged. The right arm was imaged first in each
case. After a resting period of at least 20 min, 1 min of baseline recording of the brachial artery diameter
was performed. Subsequently, the occlusion cuff was inflated to >200 mmHg for 5 min [22]. To estimate
brachial artery shear stress, peak shear rate was calculated as follows: peak SR = maximal flow velocity
(mm/s)/baseline diameter (mm). Normalized brachial artery FMD was calculated to account for the
peak shear rate using the following equation: normalization of brachial artery flow-mediated dilation
(FMDn) = brachial artery FMD/peak shear rate x 100. Brachial artery diameter recording was restarted
at least 30 s before cuff deflation and continued for 3 min thereafter. Peak artery diameter and the
time to reach this peak after cuff deflation were recorded. The intra-session coefficient of variations
was ≤1% for the baseline diameter. Reliability, estimated by intra-class correlation coefficients (ICCs)
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based on four baseline measurements (n = 8 subjects), showed an ICC of 0.91 for baseline diameter
and 0.83 for FMD.
Aortic pulse wave velocity (PWV) was measured with the oscillometric method using the
occlusion technique [23] by Arteriograph (TensioMedTM software v 1.9.9.2, Mexglobal SA, Budapest,
Hungry). A detailed description of the PWV technique can be found elsewhere [23]. Outcome measures
were assessed by personnel blinded.
2.4. Dietary Inflammatory Index
The DII was calculated from 28 food parameters, including carbohydrates, proteins, fats, fiber,
iron, zinc, magnesium, vitamin A, vitamin C, vitamin B6, vitamin B12, vitamin E, vitamin D,
thiamine, riboflavin, niacin, selenium, folic acid, saturated fats, monounsaturated fats, polyunsaturated
fats, omega 3 fatty acids, omega 6 fatty acids, trans-type fatty acids, β-carotene, and caffeine.
Food consumption was estimated from a 24 h dietary record (mean between one weekday and
one weekend day). Data were checked by a nutritionist, and standard household measures were
used. DII scores were recoded as a pro-inflammatory diet (positive values) or anti-inflammatory diet
(negative values) based on previous studies [24].
2.5. Statistical Analysis
All statistical analyses were performed using the Statistical Package for the Social
Sciences®software, version 22 for Windows (SPSS®, Inc., IBM, Chicago, IL, USA).
The Kolmogorov–Smirnov normality test was conducted before association analysis. Continuous
variables were presented as mean ± standard deviation and categorical variables were presented as
frequencies and percentages (n and %). The differences were estimated using Student’s t- or chi-square
tests depending on the type of variable. DII scores were recoded as a pro-inflammatory diet (positive
values) (≥2.03, min/max (0.13 to 3.64); n = 77) or anti-inflammatory diet (negative values) (≤ −1.26,
min/max (−3.71 to −0.37); n = 13). Partial Pearson correlation coefficients between the DII and the
cardiometabolic risk parameters adjusted for age and gender were performed. The significance level
was set at p < 0.05. The DII score ranged between −3.71 and 3.64.
3. Results
The anthropometric, body composition, metabolic markers, and endothelial function variables
assessed in this study are shown according to the categories of the DII score in Table 1. The mean age
of the study population was 39.7 ± 6.9 years and the mean BMI was 30.0 ± 3.5 kg/m2. Lower DII
score (anti-inflammatory diet) was significantly associated with higher HDL-C (38.7 mg/dL ± 9.2) and
FMD (12.3% ± 7.9) and lower Hb1Ac (5.3% ± 0.5) and MetScore (p < 0.05). For the anthropometric,
body composition, and blood pressure measurements, no significant differences among the categories
of the DII were identified. Statistically significant differences were identified between the categories of
the DII and normalized brachial artery FMD (Figure 1).
Table 2 shows the macro- and micronutrients intakes according to the categories of the DII. Higher
intakes of fiber, iron, zinc, magnesium, vitamin A, vitamin C, thiamine, riboflavin, niacin, omega 3,
vitamin B6, folic acid, vitamin B12, beta-carotene, vitamin E, and vitamin C were observed in the
anti-inflammatory category compared to the pro-inflammatory category (p < 0.05).
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Table 1. Anthropometric characteristics, body composition, metabolic biomarkers, and endothelial
function variables according to the categories of the DII.
Characteristic Anti-InflammatoryDiet (n = 13)
Pro-Inflammatory
Diet (n = 77) p Value
Anthropometry
Age (years) 39.2 (7.2) 39.8 (6.9) 0.756
Weight (kg) 78.6 (13.7) 79.9 (11.6) 0.497
Height (cm) 164.3 (9.5) 162.4 (7.7) 0.206
Waist circumference (cm) 90.3 (10.1) 92.7 (9.3) 0.815
Hip circumference (cm) 105.9 (6.7) 106.5 (8.2) 0.327
Body mass index (kg/m2) 28.9 (2.8) 30.2 (3.6) 0.245
Nutritional state
Overweight n (%) 8 (61.5) 41 (53.2) 0.714
Obesity n (%) 5 (38.5) 36 (46.8) 0.461
Body composition
DXA trunk tissue (% fat) 41.4 (5.3) 43.7 (5.9) 0.437
DXA trunk lean (g) 21,913.1 (4418.1) 21,458.6 (3425.7) 0.105
DXA gynecoid tissue (% fat) 37.6 (8.7) 39.5 (8.7) 0.944
DXA gynecoid lean (g) 7405.9 (1909.5) 7087.2 (1307.0) 0.113
DXA android tissue (% fat) 44.0 (5.8) 46.3 (6.3) 0.424
DXA android lean (g) 3237.4 (662,9) 3196.8 (521.9) 0.393
DXA total tissue (% fat) 38.2 (6.2) 39.5 (6.5) 0.677
DXA total tissue (kg lean mass) 46.7 (10.6) 45.9 (8.0) 0.065
Quotient trunk/total 0.54 (0.05) 0.55 (0.06) 0.306
Quotient legs/total 0.32 (0.06) 0.31 (0.06) 0.598
Quotient arms + legs/trunk 0.80 (0.19) 0.77 (0.21) 0.561
Quotient tissue android/gynecoid 1.20 (0.24) 1.20 (0.24) 0.948
Appendicular index (kg/m2) 7.7 (1.2) 7.9 (1.1) 0.394
Fat-free lean mass index (kg/m2) 10.5 (2.4) 11.5 (3.0) 0.380
Metabolic markers
TC (mg/dL) 162.8 (30.2) 159.2 (38.1) 0.373
Triglycerides (mg/dL) 158.9 (87.8) 194.5 (121.8) 0.379
HDL-C (mg/dL) 38.7 (9.2) 31.8 (5.1) 0.010
LDL-C (mg/dL) 99.8 (33.7) 94.1 (27.9) 0.372
Glucose (mg/dL) 87.7 (8.1) 92.5 (11.9) 0.070
MetScore −0.176 (2.783) 1.812 (2.356) 0.017
HbAc1 (%) 5.3 (0.5) 5.8 (0.4) 0.003
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Table 1. Cont.
Characteristic Anti-InflammatoryDiet (n = 13)
Pro-Inflammatory
Diet (n = 77) p Value
Markers of endothelial function
FMD (%) 12.3 (7.9) 6.7 (5.4) 0.015
Baseline diameter, mm 3.2 (0.5) 3.1 (0.3) 0.490
Reactive hyperemia diameter, mm 3.6 (0.7) 3.3 (0.4) 0.029
Baseline flow velocity, cm/s 80.4 (24.5) 81.9 (24.0) 0.836
Reactive hyperemia diameter, flow velocity, cm/s 152.8 (33.5) 135.3 (35.2) 0.107
Peak Shear rate, s 483.2 (118.0) 423.6 (99.9) 0.054
PWV (m/s) 7.0 (0.6) 7.3 (1.1) 0.082
Aortic systolic pressure (mm Hg) 110.7 (6.8) 111.0 (11.2) 0.889
Aortic pulse pressure (mm Hg) 39.1 (6.3) 38.8 (7.4) 0.886
Brachial augmentation index (%) 20.6 (11.4) 23.7 (19.0) 0.435
Aortic augmentation index (%) −33.6 (22.4) −20.8 (27.2) 0.082
Blood pressure
SBP (mm Hg) 115.3 (9.7) 117.5 (7.5) 0.335
DBP (mm Hg) 71.5 (7.2) 72.2 (9.7) 0.767
MAP (mm Hg) 87.0 (6.5) 86.6 (9.2) 0.884
Data are shown as mean ± SD or frequencies n (%). The categories of the DII were compared using Student’s t-tests
for continuous variables and chi-squared tests for categorical variables. DXA: Dual energy X-ray absorptiometry;
TC: total cholesterol; c-HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein cholesterol;
Hb1Ac: glycated hemoglobin; FMD: flow-mediated vasodilation; PWV: pulse wave velocity; SBP: systolic blood
pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure. The MetScore was calculated from
the sum of the typified residuals (Z) of cardiovascular risk variables: ((♂40 or ♀50 − HDL-C)/SD × (−1))) +
((triglycerides − 150)/SD) + ((glucose − 100)/SD) + ((CC − ♂94 or ♀80)/SD) + ((MAP − 100)/SD, adjusted for
gender and age.
Table 2. Nutrient intake according to the categories of the DII.
Nutrients Anti-Inflammatory Diet(n = 13)
Pro-Inflammatory Diet
(n = 77) p Value
Energy (kcal) 2043.7(656.1) 1820.3 (602.4) 0.239
Protein (g) 85.1 (33.8) 74.4 (27.2) 0.219
Total fat (g) 81.8 (34.1) 72.8 (23.5) 0.252
Carbohydrate (g) 265.2 (149.4) 214.4 (86.6) 0.093
Fiber (g) 42.9 (50.1) 14.7 (6.4) <0.000
Iron (mg) 30.1 (32.9) 14.4 (9.3) 0.001
Zinc (mg) 13.2 (4.5) 8.9 (5.2) 0.008
Magnesium (mg) 896.5 (699.8) 462.5 (575.8) 0.020
Vitamin A (RE) 1183.1 (946.9) 657.1 (647.3) 0.016
Vitamin C (mg) 146.6 (56.2) 69.6 (58.3) <0.000
Thiamin (mg) 5.0 (5.4) 1.7 (1.3) <0.000
Riboflavin (mg) 3.2 (4.9) 1.2 (0.5 ) <0.000
Niacin (mg) 28.2 (28.6) 15.3 (6.3) 0.001
Saturated fatty acid (g) 19.6 (10.3) 19.0 (9.1) 0.841
Mono-unsaturated fatty acid (g) 23.7 (17.0) 18.3 (8.2) 0.080
Polyunsaturated fatty acid (g) 39.1 (75.1) 19.2 (29.5) 0.096
Cholesterol (mg) 178.9 (112.4) 250.8 (199.8) 0.228
Trans fat (g) 0.2 (0.8) 0.4 (2.8) 0.854
Omega 6 (g) 33.7 (69.8) 21.1 (57.1) 0.492
Omega 3 (g) 2.3 (1.8) 1.8 (0.6) 0.046
Vitamin B6 (mg) 9.7 (21.6) 0.9 (0.4) <0.000
Selenium (µg) 59.3 (35.6) 56.0 (44.3) 0.806
Folic acid (mg) 951.5 (2283.9) 34.9 (57.6) <0.000
Vitamin B12 (µg) 11.6 (23.2) 2.5 (1.91) 0.001
Beta Carotene (µg) 2824.8 (2195.1) 1458.7 (1986.2) 0.031
Vitamin E (mg) 7.5 (4.5) 3.9 (2.2) <0.000
Vitamin D (µg) 4.8 (7.5) 2.5 (2.0) 0.028
Caffeine (g) 0.7 (2.3) 0.2 (1.2) 0.299
Data are shown as mean (SD).
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Table 3 shows partial correlations adjusted for age and gender. Lower DII score (anti-inflammatory
diet) was inversely correlated with plasma triglyceride levels (r = −0.354, p < 0.05), glucose (r = −0.422,
p < 0.05), MetScore (r = −0.228, p < 0.05), and PWV (r = −0.437, p < 0.05) and positively correlated
with FMD (r = 0.261, p < 0.05). On the contrary, higher DII score (pro-inflammatory diet) showed
a positive relationship with MetScore (r = 0.410, p < 0.05) and a negative relationship with FMD
(r = −0.233, p < 0.05). Forty percent of the subjects had a MetScore ≥1, showing statistically significant
differences among the categories of the DII categories. An anti-inflammatory diet was inversely
correlated with percentage of fat tissue and total cholesterol values; however, these associations were
not statistically significant.
Table 3. Partial correlations between percentage of fat, metabolic markers, and endothelial function
according to the categories of the DII.
Characteristic Anti-Inflammatory Diet(n = 13)
Pro-Inflammatory Diet
(n = 77)
DXA total tissue (% fat) −0.122 0.111
TC (mg/dL) −0.210 0.010
Triglycerides (mg/dL) −0.354 * −0.009
HDL-C (mg/dL) −0.100 0.028
LDL-C (mg/dL) 0.350 −0.084
Glucose (mg/dL) −0.422 * −0.228
MetScore −0.282 * 0.410 *
HbAc1 (%) 0.004 0.090
FMDn (%) 0.261 * −0.233 *
PWV (m/s) −0.437 * 0.014
Aortic systolic pressure (mm Hg) −0.271 −0.126
Aortic pulse pressure (mm Hg) −0.271 −0.055
Brachial augmentation index (%) −0.300 −0.209
Aortic augmentation index (%) −0.299 −0.064
MAP (mm Hg) −0.011 0.079
* p < 0.05 through Pearson’s correlation. TC: total cholesterol; HDL-C: high-density lipoprotein-cholesterol;
LDL-C: low-density lipoprotein cholesterol; Hb1Ac: glycated hemoglobin; FMD: flow-mediated vasodilation;
PWV: pulse wave velocity; MAP: mean arterial pressure. The MetScore was calculated from the sum of the typified
residuals (Z) of cardiovascular risk variables: ((♂40 or ♀50 − HDL-C)/SD × (−1)) + ((triglycerides − 150)/SD) +
((glucose − 100)/SD) + ((CC − ♂94 or ♀80)/SD) + ((MAP − 100)/SD, adjusted for gender and age.
4. Discussion
Adherence to a healthy dietary pattern has been postulated as a determinant factor in regulating
inflammatory markers [6,24]. Despite previous research have reported that the DII was associated with
several inflammatory processes including obesity or certain cancers, this study, the first of its kind,
investigated the relationship between the DII and cardiometabolic risk parameters was investigated in
a cohort of overweight/obese and sedentary adults from Bogotá, Colombia. Our data demonstrate that
an anti-inflammatory diet was significantly associated with higher HDL-C and FMD values, as well as
lower Hb1Ac and MetScore values, after adjusting for age and gender, thereby supporting the benefits
of an anti-inflammatory diet in regard to parameters related to CVD.
To the best of our knowledge, this is the first study to evaluate the association between the
DII and markers of endothelial function. Our results indicate that a more anti-inflammatory diet
profile is associated with improved endothelial function, showing an inverse relationship with PWV
and a positive relationship with FMD. These findings were in concordance with previous studies in
which the association between healthy dietary patterns and parameters of endothelial function was
investigated [8,10,25,26]. Rallidis et al. [25] demonstrated that close adherence to a Mediterranean diet
in subjects with abdominal obesity increases FMD and decreases diastolic blood pressure (DBP) and
insulin resistance (HOMA-IR). Similarly, the Mediterranean-style dietary pattern improved markers of
endothelial function in patients with metabolic syndrome [26]. These data are in line with a recent
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meta-analysis that found that a Mediterranean diet reduces inflammation and improves endothelial
function [10]. Furthermore, a lower intake of fiber, polyunsaturated fats, and vegetable protein and
a higher intake of cholesterol were associated with increasing impairment of endothelial function
in patients with type I diabetes [27]. Interestingly, a prospective study conducted by our research
group in a Colombian population supported the contribution of postprandial lipemia to endothelial
dysfunction [8].
With regard to conventional cardiovascular risk factors, we observed that an anti-inflammatory
diet was related to higher HDL-C and lower Hb1Ac levels. Furthermore, correlation analysis
identified that an increased anti-inflammatory potential of diet was inversely associated with plasma
glucose and triglyceride levels. These results are in line with data from the Supplémentation en
Vitamines et Minéraux AntioXydants (SU.VI.MAX) study conducted in a cohort of 3726 subjects,
which demonstrated that a pro-inflammatory diet was associated with higher triglyceride and lower
HDL-C levels [16]. Similarly, Sokol et al. reported an inverse relationship between the DII and HDL-C
in a Polish population of 3862 participants [28]. Taking into account our association findings and the
above lines of evidence, a pro-inflammatory diet might have a negative effect on the cardiometabolic
risk profile across different populations [29–32].
On the other hand, this study identified an inverse association between an anti-inflammatory
diet and the cardiometabolic risk score (MetScore). Previous works have explored the relationship
between the DII and components of metabolic syndrome, yielding inconsistent conclusions [16,28,33].
In the SU.VI.MAX study, the odds of metabolic syndrome were 39% higher among subjects with
a pro-inflammatory diet than in those with an anti-inflammatory diet [16]. Conversely, other authors
have reported a lack of association between the DII and the MetScore [28,33]. It is interesting to note
that in our study the prevalence of metabolic syndrome was 40%, whereas in the above-mentioned
studies it was 30% and 28%, respectively. Thus, the contradictory results may be explained by the
differences in the prevalence of metabolic syndrome across study cohorts.
The mechanisms by which an anti-inflammatory diet may regulate low-grade inflammation in
cardiometabolic diseases are not certain. Nonetheless, it has been hypothesized that unhealthy dietary
patterns with pro-inflammatory properties could trigger an innate immune response related to an
increased production of pro-inflammatory cytokines and reduced production of anti-inflammatory
cytokines, promoting states of chronic inflammation and consequently an increased risk of endothelial
dysfunction, metabolic syndrome, and CVD [34,35].
In this study, we reported no significant differences in any anthropometric parameters or body
composition variables among the categories of the DII. It is worth noting that we evaluated, for the
first time, the possible relationship between the DII and measurements of body composition using
a DXA device. Although the Prevención con Dieta Mediterránea (PREDIMED) study demonstrated
significant associations between the DII and anthropometric data, only BMI, WC, and WHtR
variables were investigated [15]. Moreover, the fact that the participants included in this study
had similar anthropometric characteristics due to the inclusion criteria could explain the lack of
significant associations reported in this study. Hence, further studies conducted in populations with
heterogeneous anthropometric variables are needed to clarify this issue.
The present study has some limitations. First, due to its cross-sectional design, no causal
conclusions can be drawn. Secondly, the DII was calculated from 24 h dietary records. Although the
literature supports its use as a pertinent method for assessing nutrient intake, under-reporting of food
intake is a limiting factor in self-reported questionnaires [36]. In order to improve the accuracy of
the food descriptions, data entries were checked by a nutritionist and standard household measures
were used. Another potential limitation is the major difference in sample size identified between
anti-inflammatory diet group (n = 13) and pro-inflammatory diet group (n = 77). Finally, the DII score
was calculated based on 28 of the 45 nutritional parameters of the original DII. The rest of the dietary
components were not included due to their low self-reporting. Nevertheless, a previous study has
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indicated that their absence has no effect on DII scores, since these dietary components are not usually
consumed by the population [37].
On the other hand, the main strength of the present study is that it is the first to
investigate the relationship between the inflammatory potential of diet, as measured by the DII,
and cardiometabolic risk parameters in a Latin American population. Since there have been
no published studies conducted in populations of South and Central America, this could imply
that our findings may not be generalizable to those reported in other populations with different
dietary habits. Future population-based studies, and especially longitudinal studies, are required
to evaluate the discriminatory power of the DII in Colombian subjects with different criteria and
cardiovascular markers.
5. Conclusions
In summary, our results suggest that an increased anti-inflammatory potential of diet, as measured
by the DII, was associated with an improved cardiometabolic profile. These findings underline the
importance of promoting anti-inflammatory nutrition as an effective strategy for preventing CVD.
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